image_alt_text
9

Samuel Achilefu, Ph.D.

AIMBE College of Fellows Class of 2019
For outstanding contributions to near-infrared molecular imaging and image-guided surgical resection of cancer, for innovative technologies in biomedical engineering.

Disrupted flow of brain fluid may underlie neurodevelopmental disorders

Via Washington University in St. Louis | February 9, 2023

The brain floats in a sea of fluid that cushions it against injury, supplies it with nutrients and carries away waste. Disruptions to the normal ebb and flow of the fluid have been linked to neurological conditions including Alzheimer’s disease and hydrocephalus, a disorder involving excess fluid around the brain.

Researchers at Washington University School of Medicine in St. Louis created a new technique for tracking circulation patterns of fluid through the brain and discovered, in rodents, that it flows to areas critical for normal brain development and function. Further, the scientists found that circulation appears abnormal in young rats with hydrocephalus, a condition associated with cognitive deficits in children… Continue reading.

Achilefu recruited to lead new Department of Biomedical Engineering

Via UT Southwestern Medical Center | January 26, 2022

Molecular imaging expert Samuel Achilefu, Ph.D., will join UT Southwestern Feb. 1 as the first Chair of a new Department of Biomedical Engineering. Dr. Achilefu was recruited to UTSW from the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis.

He worked at Washington University for more than 20 years, most recently as a Professor of Radiology, Medicine, Biomedical Engineering, and Biochemistry & Molecular Biophysics. He also served as Chief of the Optical Radiology Laboratory, Vice Chair for Innovation and Entrepreneurship at the Mallinckrodt Institute of Radiology, and co-leader of the Oncologic Imaging Program of the Siteman Cancer Center. Recently, Dr. Achilefu was elected to the National Academy of Medicine, considered one of the highest honors in the fields of health and medicine… Continue reading.

Ultrashort-pulse lasers kill bacterial superbugs, spores

Via Washington University in St. Louis | November 23, 2021

Life-threatening bacteria are becoming ever more resistant to antibiotics, making the search for alternatives to antibiotics an increasingly urgent challenge. For certain applications, one alternative may be a special type of laser.

Researchers at Washington University School of Medicine in St. Louis have found that lasers that emit ultrashort pulses of light can kill multidrug-resistant bacteria and hardy bacterial spores. The findings, available online in the Journal of Biophotonics, open up the possibility of using such lasers to destroy bacteria that are hard to kill by other means. The researchers previously have shown that such lasers don’t damage human cells, making it possible to envision using the lasers to sterilize wounds or disinfect blood products… Continue reading.

Sam Achilefu elected to National Academy of Medicine

Via Washington University in St. Louis | October 18, 2021

Medical imaging scientist Samuel Achilefu, PhD, and child psychiatrist Joan L. Luby, MD, both of Washington University School of Medicine in St. Louis, have been elected to the National Academy of Medicine, a part of the National Academy of Sciences. Membership in the academy is considered one of the highest honors in the fields of health and medicine, and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

Achilefu and Luby are among 100 new members whose election to the National Academy of Medicine was announced Monday, Oct. 18. Current members of the organization elect new members based on their contributions to advancing public health, health care and medical science. All members volunteer time to serve on committees examining a broad range of health-policy issues… Continue reading.

Cancerous tumors, surrounding cells illuminated by new imaging agent

Via Washington University in St. Louis | March 31, 2020

Scientists at Washington University School of Medicine in St. Louis have developed a new imaging agent that could let doctors identify not only multiple types of tumors but the surrounding normal cells that the cancer takes over and uses as a shield to protect itself from attempts to destroy it.

The study appears March 9 in the journal Nature Biomedical Engineering.

The imaging agent, referred to as LS301, has been approved for investigational use in small clinical trials at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine. The first trial will investigate its use in imaging breast cancer… Continue reading.

Dr. Samuel Achilefu Inducted into Medical and Biological Engineering Elite

Via AIMBE | March 28, 2019

WASHINGTON, D.C.—The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Samuel Achilefu, Ph.D., Michel M. Ter-Pogossian Professor of Radiology, Director of Optical Radiology Laboratories, Washington University School of Medicine, to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”

Dr. Achilefu was nominated, reviewed, and elected by peers and members of the College of Fellows for “outstanding contributions to near-infrared molecular imaging and image-guided surgical resection of cancer, for innovative technologies in biomedical engineering.”